Afficher la notice abrégée

dc.contributor.authorLondon, Stationery Office
dc.date.accessioned2015-05-09T20:49:19Z
dc.date.available2015-05-09T20:49:19Z
dc.date.issued2008
dc.identifier.citationLondon: Stationery Office, 2008en_US
dc.identifier.isbn9780113227990
dc.identifier.urihttp://hdl.handle.net/123456789/502
dc.description.abstractThe British Pharmacopoeia (BP)" is the authoritative, current collection of standards for UK medicinal substances and the official source of all UK pharmaceutical quality standards. It is an essential reference for anyone involved in pharmaceutical research, development, manufacture and testing, and plays a vital role in ensuring that all medicinal substances on the UK market meet standards of safety, quality and efficacy.The BP comprises monographs, which set out the mandatory standards for active substances, excipients and formulated preparations, together with supporting General Notices, Appendices (test methods, reagents, etc) and Reference Spectra. it includes Medicinal Substances, Formulated Preparations, Blood related Preparations, Immunological Products, Radiopharmaceutical Preparations, Surgical Materials, Homeopathic Preparations.en_US
dc.language.isoenen_US
dc.publisherStationery Officeen_US
dc.relation.ispartofseriesBritish Pharmacopoeia Commission;
dc.titleBritish pharmacopoeiaen_US
dc.typeBooken_US


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée